Physician profile
Mark S Shachner
NPI 1568464410
$71,449.84
in general payments reported to CMS, 2019-2025
29 companies · $6,798 in 2025
The $6,798 reported for 2025 was more than what 93% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $12K · 2021: $15K · 2022: $14K · 2023: $1,946 · 2024: $3,332 · 2025: $6,798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,064 · Travel and Lodging: $2,152 · Education: $860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,064.32 |
| Travel and Lodging | $2,152.08 |
| Education | $859.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $25,360.14 | 2019-2022 | |
| Ethicon US, LLC | $19,934.20 | 2019-2024 | Vistaseal, Echelon Flex, Harmonic |
| Intuitive Surgical, INC. | $15,024.10 | 2019-2025 | Da Vinci Surgical System |
| Tela Bio, INC. | $3,510.50 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Davol INC. | $2,036.99 | 2020-2025 | Phasix Mesh |
| W. L. Gore & Associates, INC. | $1,165.30 | 2023-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Enform Preperitoneal Biomaterial |
| Medtronic, INC. | $886.97 | 2021-2023 | Endoflip |
| Kerecis Limited | $582.41 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Boston Scientific Corporation | $425.20 | 2022-2023 | Spyglass Discover |
| Phathom Pharmaceuticals, INC. | $225.33 | 2024 | Voquezna |
| Biotissue Holdings INC. | $195.46 | 2022-2023 | |
| Innovation Technologies INC | $188.15 | 2024 | Irrisept |
| Integra Lifesciences Corporation | $154.41 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Zimmer Biomet Holdings, INC. | $153.13 | 2023 | Ribfix Blu Advantage |
| Access Pro Medical, LLC | $140.31 | 2025 | Matriderm |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $134.42 | 2025 | |
| Solventum Corporation | $133.91 | 2025 | Abthera Advance, V.A.C. Veraflo Cleanse Choice |
| Acera Surgical, INC. | $132.07 | 2025 | Restrata Wound Matrix |
| Atricure, INC. | $120.55 | 2024 | |
| Endomagnetics Ltd | $119.09 | 2022 | |
| Ambu INC. | $118.85 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $115.12 | 2025 | |
| Merck Sharp & Dohme LLC | $114.52 | 2019 | |
| Endogastric Solutions, INC | $112.00 | 2021 | |
| Covidien Lp | $103.13 | 2019 | |
| Lexington Medical, INC. | $83.33 | 2023 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Conmed Corporation | $80.00 | 2022 | |
| Lucid Diagnostics INC. | $61.45 | 2025 | |
| Ethicon INC. | $38.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Shachner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.